Filing Details

Accession Number:
0001437749-25-019958
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-10 15:06:06
Reporting Period:
2025-06-09
Filing Date:
2025-06-10
Accepted Time:
2025-06-10 15:06:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385818 Aytu Biopharma Inc AYTU Pharmaceutical Preparations (2834) 470883144
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640724 Jarrett Disbrow C/O Aytu Biopharma, Inc.
7900 East Union Avenue, Suite 920
Denver CO 80237
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-09 16,666 $1.50 29,462 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.
  2. Total reflects 1-to-20 reverse stock split effected by the Issuer on January 6, 2023.